MedPath

PROPOFOL INJECTION

PROPOFOL INJECTION

Approved
DIN Number

02525879

Drug Class

Human

Market Date

Apr 18, 2023

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02525879
AIG Number0121833001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01AX10 PROPOFOL
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntravenous
AHFS Classification28:04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PROPOFOLActive
Strength: 10 MG / ML
Monograph: PROPOFOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.